Analyst Viewpoint
Growth in incidence of degenerative neurological disorders is a prominent factor driving the global neuroscience market size. Technological advancements in the field of neuroscience such as generative AI, brain-computer interfaces, and portable MRI units are also fostering market expansion.
These technologies facilitate early detection of neurological disorders, thereby minimizing long-term impairments, as treatments are initiated by healthcare professionals during the prodromal phase.
Companies operating in the global neuroscience market are exploring the area of connectomics, which is the creation of detailed structural connectivity maps where every neuron can be seen clearly.
Leading players can use this information to devise further advanced technologies needed to study the context of human behavior, right from making decisions to executing them.
Neuroscience refers to study of the nervous system, right from its structure, function, and development to degeneration. A human brain has 86 billion neurons. Neurobiology constitutes the study of the cells and tissues that form the nervous system.
Epilepsy, brain cancer, Alzheimer’s, and traumatic brain injuries constitute some of the neurological disorders. Brain function exploration is carried out through neuroimaging, which includes functional MRI and electroencephalography (EEG). Functional MRI and EEG are also used to review changes in brain activity.
Cognitive neuroscience entails the study of neural substrates of mental processes. It is the point of intersection between neuroscience and psychology.
Cognitive brain function exploration is generally recommended for the elderly population, as this population group is at a higher risk of age-related mental disorders such as Alzheimer’s and dementia.
Neuroscience industry growth revolves around delving deeper into cellular, behavioral, operative, molecular, evolutionary, and therapeutics aspects of the neuro system.
Increase in adoption of AI in the healthcare sector, especially in the neuroscience sphere, and constant developments in MRI machines such as introduction of smaller, portable, and cost-effective alternatives are some of the latest neuroscience market trends.
In conclusion, rise in prevalence of neurological diseases, growth in research-oriented support by academic & research institutes, and increase in funding by government and private agencies are boosting neuroscience market development.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Increase in neurological disorders has become a prominent challenge for healthcare professionals worldwide. Rise in lifespan has led to a substantial increase in the geriatric population.
The elderly population is at a higher risk of contracting degenerative neurological disorders such as the Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
According to the Alzheimer’s Association, nearly six million Americans aged 65 and above had Alzheimer’s in 2020. This figure is likely to reach 13 million by 2050.
As per the World Alzheimer Report published in 2021, more than 55 million individuals were suffering from dementia worldwide. The figure is expected to reach 78 million by 2030.
In 2021, the Brain Aneurysm Foundation revealed that more than 6.5 million individuals in the U.S. are battling unruptured brain aneurysm.
According to the World Federation of Neurology, neurological disorders are the second largest cause of fatality and one of the leading causes of disability at the global level. It further states that the medications available are insufficient for these disorders.
As per a paper published in The Lancet Neurology in October 2023, if measures for improving stroke surveillance and acute care are not taken, the number of people succumbing to stroke will increase by 50% across the globe.
Thus, surge in nervous system-related disorders is one of the leading neuroscience market drivers.
Technological advancements are being incorporated in the neuroscience sector in order to improve neurofeedback systems.
The U.S. Government recently launched the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) program for devising investigational methods to understand the working of the human brain.
Healthcare digitalization has also enabled better management of neurological disorders. In May 2023, Nicholas Opie and Dr. Thomas Oxley, Australia-based researchers, developed a human brain computer interface system to send data from the patient’s brain remotely for controlling external digital devices, thereby enabling paralyzed patients to communicate.
In May 2023, Koninklijke Philips N.V. introduced an AI-powered CT system called the Philips CT 3500 for executing high-volume screening programs. The device aims to deliver high quality images to radiologists for precise diagnosis.
Introduction of such brain-machine interface technologies in neuroscience is bolstering the neuroscience industry.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America held the largest neuroscience market share in 2022. The region is expected to maintain its dominance during the forecast period. This can be ascribed to availability of extensive funding by government agencies and private organizations alike for devising cutting-edge neuroscience research techniques in the region.
As per the National Institute of Health, funding for neurodegenerative diseases stood at US$ 4.1 Bn in 2021.
In May 2021, Sens.ai was introduced as the first at-home neuro optimization system that incorporated brain training with heart coherence training in order to help people manage stress.
Speedy approval of such innovative products from agencies such as the U.S. FDA is also driving market statistics in North America.
The neuroscience market forecast appears promising in Asia Pacific, led by the introduction of various initiatives in the field of neuroscience in countries such as China and India.
In September 2022, China introduced the China Brain Project (CBP) that focuses on brain-inspired computing, use of neuroinformatics and Big Data in neuroscience, therapeutic innovations in neurological disorders, and neuroimaging modalities and clinical applications.
Companies operating in the global neuroscience landscape are engaged in obtaining product approvals from regulatory bodies such as the U.S. FDA. They are also devising inorganic growth strategies to expand their offerings.
In May 2023, the U.S. FDA granted clearance to Neurophet AQUA, a brain MRI software that analyzes brain atrophy and white matter hyperintensities (WMH) observed in neurodegenerative diseases such as Alzheimer's disease and vascular dementia.
Noldus Information Technology BV, in June 2022, announced that it had entered into a collaborative agreement with Inscopix to access EthoVision XT video tracking software to be able to establish accurate correlations between rodent behavior and brain activity.
NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Inc., Cercare Medical A/S, Plexon, Inc., Noldus Information Technology B.V., Femtonics Ltd., Neuralynx, Inc., Neurable, Inc., Bitbrain Technologies, Halo Neuroscience, and NeuroNexus Technologies, Inc. are some of the key players covered in the neuroscience market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 30.1 Bn |
| Market Forecast (Value) in 2031 | US$ 41.6 Bn |
| Growth Rate (CAGR) | 3.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 30.1 Bn in 2022
It is projected to grow at a CAGR of 3.7% from 2023 to 2031
Growth in prevalence of degenerative neurological disorders and advancements in technologies
The hospitals segment accounted for the largest share in 2022
North America was the dominant region in 2022
NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Inc., Cercare Medical A/S, Plexon, Inc., Noldus Information Technology B.V., Femtonics Ltd., Neuralynx, Inc., Neurable, Inc., Bitbrain Technologies, Halo Neuroscience, and NeuroNexus Technologies, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neuroscience Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neuroscience Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Neuroscience Market Analysis and Forecast, by Component
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2017–2031
6.3.1. Instrument
6.3.2. Software
6.3.3. Services
6.4. Market Attractiveness Analysis, by Component
7. Global Neuroscience Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. Whole Brain Imaging
7.3.2. Neuro-microscopy
7.3.3. Electrophysiology
7.3.4. Neuroproteomics Analysis
7.3.5. Animal Behavior Analysis
7.3.6. Neuro-functional Analysis
7.3.7. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Neuroscience Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Academic & Research Institutions
8.3.4. Others
8.4. Market Attractiveness Analysis, by Technology
9. Global Neuroscience Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Neuroscience Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2017–2031
10.3.1. Instrument
10.3.2. Software
10.3.3. Services
10.4. Market Value Forecast, by Technology, 2017–2031
10.4.1. Whole Brain Imaging
10.4.2. Neuro-microscopy
10.4.3. Electrophysiology
10.4.4. Neuroproteomics Analysis
10.4.5. Animal Behavior Analysis
10.4.6. Neuro-functional Analysis
10.4.7. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Diagnostic Laboratories
10.5.3. Academic & Research Institutions
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By Technology
10.7.3. By End-user
10.7.4. By Country
11. Europe Neuroscience Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2017–2031
11.3.1. Instrument
11.3.2. Software
11.3.3. Services
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Whole Brain Imaging
11.4.2. Neuro-microscopy
11.4.3. Electrophysiology
11.4.4. Neuroproteomics Analysis
11.4.5. Animal Behavior Analysis
11.4.6. Neuro-functional Analysis
11.4.7. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Academic & Research Institutions
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Technology
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Neuroscience Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2017–2031
12.3.1. Instrument
12.3.2. Software
12.3.3. Services
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Whole Brain Imaging
12.4.2. Neuro-microscopy
12.4.3. Electrophysiology
12.4.4. Neuroproteomics Analysis
12.4.5. Animal Behavior Analysis
12.4.6. Neuro-functional Analysis
12.4.7. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Academic & Research Institutions
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By Technology
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Neuroscience Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2017–2031
13.3.1. Instrument
13.3.2. Software
13.3.3. Services
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Whole Brain Imaging
13.4.2. Neuro-microscopy
13.4.3. Electrophysiology
13.4.4. Neuroproteomics Analysis
13.4.5. Animal Behavior Analysis
13.4.6. Neuro-functional Analysis
13.4.7. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Academic & Research Institutions
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Technology
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Neuroscience Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2017–2031
14.3.1. Instrument
14.3.2. Software
14.3.3. Services
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Whole Brain Imaging
14.4.2. Neuro-microscopy
14.4.3. Electrophysiology
14.4.4. Neuroproteomics Analysis
14.4.5. Animal Behavior Analysis
14.4.6. Neuro-functional Analysis
14.4.7. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Academic & Research Institutions
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Technology
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. NEURALINK
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Kernel
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. BrainCo, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. MindMaze
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Paradromics
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. NeuroPro
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. NeuroSky
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. EMOTIV, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Cercare Medical A/S
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Plexon, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Noldus Information Technology B.V.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Femtonics Ltd.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Neuralynx, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Neurable, Inc.
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
15.3.15. Bitbrain Technologies
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Financial Overview
15.3.15.5. Strategic Overview
15.3.16. Halo Neuroscience
15.3.16.1. Company Overview
15.3.16.2. Product Portfolio
15.3.16.3. SWOT Analysis
15.3.16.4. Financial Overview
15.3.16.5. Strategic Overview
15.3.17. NeuroNexus Technologies, Inc.
15.3.17.1. Company Overview
15.3.17.2. Product Portfolio
15.3.17.3. SWOT Analysis
15.3.17.4. Financial Overview
15.3.17.5. Strategic Overview
List of Tables
Table 01: Global Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 02: Global Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 03: Global Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Neuroscience Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Neuroscience Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 07: North America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 08: North America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 11: Europe Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 12: Europe Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 15: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 16: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 19: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 20: Latin America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031
Table 23: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 24: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Neuroscience Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Neuroscience Market Revenue (US$ Mn), by Component, 2022
Figure 03: Global Neuroscience Market Value Share, by Component, 2022
Figure 04: Global Neuroscience Market Revenue (US$ Mn), by Technology, 2022
Figure 05: Global Neuroscience Market Value Share, by Technology, 2022
Figure 06: Global Neuroscience Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Neuroscience Market Value Share, by End-user, 2022
Figure 08: Global Neuroscience Market Value Share, by Region, 2022
Figure 09: Global Neuroscience Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 11: Global Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 12: Global Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 13: Global Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 14: Global Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Neuroscience Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Neuroscience Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Neuroscience Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Neuroscience Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 22: North America Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 23: North America Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 25: North America Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 26: North America Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 31: Europe Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 32: Europe Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 34: Europe Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 35: Europe Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 40: Asia Pacific Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 41: Asia Pacific Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 43: Asia Pacific Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 44: Asia Pacific Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 49: Latin America Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 50: Latin America Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 52: Latin America Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 53: Latin America Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Neuroscience Market Value Share Analysis, by Component, 2022–2031
Figure 58: Middle East & Africa Neuroscience Market Value Share Analysis, by Technology, 2022–2031
Figure 59: Middle East & Africa Neuroscience Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Component, 2023–2031
Figure 61: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031
Figure 62: Middle East & Africa Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Neuroscience Market
